Autolus Therapeutics (AUTL) Change in Receivables (2025)
Autolus Therapeutics (AUTL) posted quarterly Change in Receivables of -$8.6 million for Q4 2025, down 242.79% on a QoQ basis from $6.0 million in Q3 2025.
Autolus Therapeutics (AUTL) Change in Receivables (2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Change in Receivables for 1 consecutive years, with -$8.6 million the latest figure, recorded in Q4 2025.
- Quarterly Change in Receivables changed N/A year-over-year to -$8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.2 million (changed N/A YoY) and the FY2025 annual result came in at $24.2 million, changed N/A from the prior year.
- Change in Receivables declined to -$8.6 million in Q4 2025 per AUTL's latest filing, from $6.0 million in the prior quarter.
- Over the last five years, Change in Receivables for AUTL reached as high as $14.3 million in Q1 2025 and fell as low as -$8.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | -8.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.57 Mn |
| Dec 31, 2025 | -8.57 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 12.39 Mn |
| Jun 30, 2025 | 12.39 Mn |
| Mar 31, 2025 | 14.34 Mn |
| Mar 31, 2025 | 14.34 Mn |